Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgens”

1,175 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,175 results

Testing effectiveness (Phase 2)Study completedNCT03322020
What this trial is testing

Androgen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Prostate Cancer

Who this might be right for
Neoplasm, Prostate
Asan Medical Center 30
Early research (Phase 1)Ended earlyNCT00972023
What this trial is testing

DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 1
Not applicableStudy completedNCT02434562
What this trial is testing

Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation

Who this might be right for
HypogonadismEstrogensTestosterone+1 more
Universitaire Ziekenhuizen KU Leuven 73
Not applicableUnknownNCT04776915
What this trial is testing

Congenital Uterine Anomalies & Pregnancy in Polycystic Ovarian Syndrome

Who this might be right for
Mullerian Anomaly of Uterus, Nec
Uludag University 100
Testing effectiveness (Phase 2)Study completedNCT00755885
What this trial is testing

Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research UK 77
Testing effectiveness (Phase 2)Study completedNCT00589420
What this trial is testing

Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Looking for participantsNCT04989946
What this trial is testing

Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 60
Testing effectiveness (Phase 2)Study completedNCT01696877
What this trial is testing

A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer

Who this might be right for
Prostate Cancer Adenocarcinoma in Situ
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT06463457
What this trial is testing

Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Who this might be right for
Prostate CancerAdvanced Prostate CancerHormone Sensitive Prostate Cancer
Atish Choudhury, MD 33
Not applicableUnknownNCT01422759
What this trial is testing

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

Who this might be right for
ObesityHyperandrogenemiaPolycystic Ovary Syndrome
University of Virginia 20
Large-scale testing (Phase 3)Looking for participantsNCT05974774
What this trial is testing

Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,600
Not applicableStudy completedNCT03860961
What this trial is testing

Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy

Who this might be right for
Prostate Adenocarcinoma
NRG Oncology 550
Early research (Phase 1)Study completedNCT01382069
What this trial is testing

Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men

Who this might be right for
Healthy MenMale Contraception
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 100
Testing effectiveness (Phase 2)Looking for participantsNCT06844383
What this trial is testing

Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

Who this might be right for
Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostate Cancer Clinical Trials Consortium 126
Not applicableUnknownNCT05973175
What this trial is testing

REFUEL PCOS Study 1

Who this might be right for
Polycystic Ovary Syndrome
Royal College of Surgeons, Ireland 40
Testing effectiveness (Phase 2)Study completedNCT00589472
What this trial is testing

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)UnknownNCT01398657
What this trial is testing

Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer

Who this might be right for
Prostate Cancer
National Taiwan University Hospital 182
Not applicableNot Yet RecruitingNCT07476222
What this trial is testing

Predictors of Androgen Status Decline in Middle-Aged Men

Who this might be right for
Testosterone DeficiencyAndrogen DeficiencyMale Hypogonadism+1 more
Andijan State Medical Institute 600
Testing effectiveness (Phase 2)Study completedNCT00148772
What this trial is testing

Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy

Who this might be right for
Prostate Cancer
Endeavor Health 29
Not applicableStudy completedNCT01516866
What this trial is testing

Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 58
Load More Results